Name | OSI-027 HCl salt |
Iupac Chemical Name | 4-(4-amino-5-(7-methoxy-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl)cyclohexanecarboxylic acid hydrochloride. |
Synonyms | mTOR kinase inhibitor OSI-027 binds to and inhibits both the raptor-mTOR (TOR complex 1 or TORC1) and the rictor-mTOR (TOR complex 2 or TORC2) complexes of mTOR, which may result in tumor cell apoptosis and a decrease in tumor cell proliferation. mTOR is a serine/threonine kinase that is upregulated in some tumors and plays an important role downstream in the PI3K/Akt/mTOR signaling pathway. Check for active clinical trials or closed clinical trials using this agent. |
Molecular Formula | C21H23ClN6O3 |
Molecular Weight | 442.9 |
Smile | COc1cccc2c1[nH]c(c2)c3c4c(ncnn4c(n3)C5CCC(CC5)C(=O)O)N.Cl |
InChiKey | NVPWJMHJZINDTG-UHFFFAOYSA-N |
InChi | InChI=1S/C21H22N6O3.ClH/c1-30-15-4-2-3-13-9-14(25-16(13)15)17-18-19(22)23-10-24-27(18)20(26-17)11-5-7-12(8-6-11)21(28)29;/h2-4,9-12,25H,5-8H2,1H3,(H,28,29)(H2,22,23,24);1H |
CAS Number | 936890-98-1 |
MDL | MFCD18251429 |
Related CAS | |